Price$37.38-0.84 (-2.21%)
01:30 PM05:00 PM
News · 26 weeks43-62%
2025-12-142026-06-07
Mix2690d
- SEC Filings10(38%)
- Insider8(31%)
- Other4(15%)
- Earnings2(8%)
- Leadership1(4%)
- Analyst1(4%)
Latest news
25 items- PRAstrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue GrowthALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it has been named to the Fortune 1000® for 2026, marking its debut on the annual ranking of the largest U.S. companies by revenue. The recognition reflects Astrana's continued growth and momentum as it builds AI-powered healthcare infrastructure that helps providers deliver more accessible, coordinated, and affordable care.
- ANALYSTAstrana Health upgraded by Barclays with a new price targetBarclays upgraded Astrana Health from Equal Weight to Overweight and set a new price target of $50.00
- INSIDERCOO and CFO Basho Chandan covered exercise/tax liability with 8,155 shares, decreasing direct ownership by 5% to 159,610 units (SEC Form 4) (tax withholding)4 - Astrana Health, Inc. (0001083446) (Issuer)
- PRAstrana Health, Inc. Announces Appointment of Interim National Medical DirectorALHAMBRA, Calif., May 12, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointment of George Christides, M.D. as Interim National Medical Director. In this role, Dr. Christides will lead the Company's population health, care management, and care navigation initiatives across its national platform.Dr. Christides is an ac
- SECAstrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- SECAstrana Health Inc. filed SEC Form 8-K: Leadership Update8-K - Astrana Health, Inc. (0001083446) (Filer)
- PRPhysician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary CareExpands access to Astrana's Medicare ACO platform, powered by a unified AI-powered platform designed for independent physiciansALHAMBRA, Calif., May 11, 2026 /PRNewswire/ -- The Physician Association of California ("PAC") and Astrana Health, Inc. ("Astrana") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced a collaboration to help independent primary care physicians remain independent – and succeed – in an increasingly complex healthcare system while improving patient care.
- SECSEC Form 10-Q filed by Astrana Health Inc.10-Q - Astrana Health, Inc. (0001083446) (Filer)
- SECAstrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- PRAstrana Health, Inc. Reports First Quarter 2026 ResultsCompany to Host Conference Call on Thursday, May 7, 2026, at 2:30 p.m. PT/5:30 p.m. ETReports total revenue of $965.1 million, up 56% year over yearReports adjusted EBITDA(1) of $66.3 million, up 82% year over year and free cash flow(2) of $64.1 million, up 372% year over yearALHAMBRA, Calif., May 7, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2026.
- PRAstrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference CallALHAMBRA, Calif., April 21, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2026, after the close of the stock market on Thursday, May 7, 2026. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day. Par
- SECSEC Form DEFA14A filed by Astrana Health Inc.DEFA14A - Astrana Health, Inc. (0001083446) (Filer)
- SECSEC Form DEF 14A filed by Astrana Health Inc.DEF 14A - Astrana Health, Inc. (0001083446) (Filer)
- INSIDERSEC Form 4 filed by Basho Chandan4 - Astrana Health, Inc. (0001083446) (Issuer)
- PRAstrana Health, Inc. to Participate in Upcoming Investor ConferencesALHAMBRA, Calif., April 10, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The 25th Annual Needham Virtual Healthcare Conference on April 13-16, 2026The Bank of America Global Healthcare Conference 2026, being held in Las Vegas on May 12-14, 2026
- INSIDERSEC Form 4 filed by Lam Thomas S.4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERSEC Form 4 filed by Sim Kenneth T.4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERSEC Form 4 filed by Sim Brandon4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERSEC Form 4 filed by Kumar Dinesh M.4 - Astrana Health, Inc. (0001083446) (Issuer)
- INSIDERSEC Form 4 filed by Basho Chandan4 - Astrana Health, Inc. (0001083446) (Issuer)
- SECSEC Form S-3ASR filed by Astrana Health Inc.S-3ASR - Astrana Health, Inc. (0001083446) (Filer)
- SECSEC Form S-3ASR filed by Astrana Health Inc.S-3ASR - Astrana Health, Inc. (0001083446) (Filer)
- SECAstrana Health Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- INSIDERSEC Form 4 filed by Sobotka Glenn4 - Astrana Health, Inc. (0001083446) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Astrana Health Inc.SCHEDULE 13G/A - Astrana Health, Inc. (0001083446) (Subject)
ASTH FAQ
5 questionsWhere does ASTH stock trade?
Astrana Health Inc. (ASTH) is listed on NASDAQ.What sector and industry is ASTH in?
Astrana Health Inc. operates in the Consumer Discretionary sector, Professional Services industry.What are analysts saying about ASTH?
Astrana Health Inc. has had 7 recent analyst actions on file. The most recent action was from Barclays: Overweight on 2026-05-26. Recent price targets range from $2800.00 to $3600.00.What companies are similar to ASTH?
Notable peers in the same industry include GIB (CGI Inc.), BAH (Booz Allen Hamilton Holding Corporation), ASGN (ASGN Incorporated), G (Genpact Limited), FCN (FTI Consulting Inc.). Compare ASTH side-by-side with any of them on Quantisnow.How can I track ASTH on Quantisnow?
Quantisnow aggregates Astrana Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ASTH to receive live email and push alerts on every new disclosure.